Current status of alloimmunity.

Area of Science:

• Transplantation immunology
• Translational research in organ transplantation
• Clinical transplantation

Background:

• Understanding allorecognition and T cell allospecificity is crucial in transplantation.
• Challenges exist in targeting memory T cells and limitations in current animal models.
• Innate immunity plays a dual role in immune responses during transplantation.

Purpose of the Study:

• To review major recent advances in basic, translational, and clinical transplantation research.
• To highlight new concepts in alloimmunity and potential therapeutic strategies.
• To discuss novel technologies for restraining alloimmunity and improving graft survival.

Main Methods:

• Review of recent literature on allorecognition, T cell responses, and innate immunity.
• Analysis of advances in molecular biopsy characterization for risk stratification.
• Exploration of novel technologies including gene editing and drug delivery systems.

Main Results:

• New insights into T cell allospecificity and challenges in targeting memory T cells.
• Advances in molecular biopsy improve understanding of injury drivers and patient risk.
• Novel approaches like CAR T-cells, microparticle drug delivery, and CRISPR/Cas9 offer potential to restrain alloimmunity.

Conclusions:

• Enhanced understanding of alloimmunity mechanisms facilitates translation to clinical applications.
• Novel diagnostic and therapeutic strategies are emerging to improve long-term graft survival.
• Future research holds promise for more effective management of transplant rejection.